Association between CYP1A1 polymorphism and colorectal cancer risk: A meta-analysis

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 3533-3540

  Zheng, Yuan ^a   Wang, Jing Jun ^a   Sun, Liang ^a   Li, Hong Lei ^a  

^a Department of Center for Disease Control and Prevention of Shaanxi Province ^*  (China)

Author keywords

Colorectal cancer; CYP1A1 polymorphism; Meta analysis

Indexed keywords

CYTOCHROME P450 1A1; CYP1A1 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; ALLELE; BIOLOGICAL MODEL; COLORECTAL TUMOR; DOMINANT GENE; ENZYMOLOGY; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP1A1; DATABASES, GENETIC; GENE FREQUENCY; GENES, DOMINANT; GENES, RECESSIVE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS;

EID: 84862980031     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1126-2     Document Type: Article

References (44)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300. doi:10.3322/caac.20073
2. Weitz J, Koch M, Debus J, Hohler T, Galle PR et al (2005) Colorectal cancer. Lancet 365:153-165. doi:10.1016/S0140-6736 (05)17706-X
3. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I et al (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9:489-499. doi:10.1038/nrc2645
4. de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769-780. doi:10.1038/nrc1453
5. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J et al (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85. doi:10.1056/NEJM20000 7133430201
6. Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P (2010) Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am J Epidemiol 172:1000-1014. doi:10.1093/aje/kwq245
7. Preissner S, Kroll K, Dunkel M, Senger C, GoldsobelGet al (2010) SuperCYP: A comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res 38:D237-D243. doi:10.1093/nar/gkp970
8. Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162. doi:10.1016/S0140-6736 (02)11203-7
9. Nebert DW, Dalton TP (2006) The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 6:947-960. doi:10.1038/nrc2015
10. Wrensch MR, Miike R, Sison JD, Kelsey KT, Liu M et al (2005) CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. Int J Cancer 113:141-147. doi:10.1002/ijc.20537
11. Sivaraman L, Leatham MP, Yee J, Wilkens LR, Lau AF et al (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 54:3692-3695
12. Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A et al (2005) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 15:535-546
13. Hayashi S, Watanabe J, Kawajiri K (1992) High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 83:866-870
14. Ravnik-Glavac M, Dolzan V, Breskvar K (1998) Genetic polymorphisms of xenobiotic metabolizing enzymes in human colorectal cancer. Radiol Oncol 32:35-39
15. Fritsche E, Bruning T, Jonkmanns C, Ko Y, Bolt HM et al (1999) Detection of cytochrome P450 1B1 Bfr I polymorphism: Genotype distribution in healthy German individuals and in patients with colorectal carcinoma. Pharmacogenetics 9:405-408
16. Ishibe N, Stampfer M, Hunter DJ, Hennekens C, Kelsey KT (2000) A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 9:855-856
17. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R et al (2002) A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23:1839-1849
18. Ye Z, Parry JM (2002) Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen 22:385-392. doi:10.1002/tcm.10035
19. Slattery ML, Samowtiz W, Ma K, Murtaugh M, Sweeney C et al (2004) CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol 160:842-852. doi:10.1093/aje/kwh298
20. Chen K, Jin MJ, Fan CH, Song L, Jiang QT et al (2005) A casecontrol study on the association between genetic polymorphisms of metabolic enzymes and the risk of colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi 26:659-664
21. Little J, Sharp L, Masson LF, Brockton NT, Cotton SC et al (2006) Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: A case-control study in the Grampian region of Scotland. Int J Cancer 119:2155-2164. doi: 10.1002/ijc.22093
22. Kiss I, Orsos Z, Gombos K, Bogner B, Csejtei A et al (2007) Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 27:2931-2937
23. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL (2007) Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J Biomed Sci 14:183-193. doi:10.1007/s11373-006- 9139-x
24. Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K et al (2007) Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev 8:438-444
25. Kobayashi M, Otani T, Iwasaki M, Natsukawa S, Shaura K et al (2009) Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: A hospital-based case-control study inJapan. Scand J Gastroenterol 44:952-959. doi:10.1080/00365520 902964721
26. Nisa H, Kono S, Yin G, Toyomura K, Nagano J et al (2010) Cigarette smoking, genetic polymorphisms and colorectal cancer risk: The Fukuoka Colorectal Cancer Study. BMC Cancer 10:274. doi:10.1186/1471-2407-10-274
27. Rohlfs RV, Weir BS (2008) Distributions of Hardy-Weinberg equilibrium test statistics. Genetics 180:1609-1616. doi:10.1534/ genetics.108.088005
28. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. doi:10.1002/sim.1186
29. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
30. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
31. Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15-17
32. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24:1291-1306. doi:10.1002/sim.2010
33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634
34. Sergentanis TN, Economopoulos KP (2010) Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: A meta-analysis. Breast Cancer Res Treat 122:459-469. doi: 10.1007/s10549-009-0694-5
35. Jin JQ, Hu YY, Niu YM, Yang GL, Wu YY et al (2011) CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: A meta-analysis. World J Gastroenterol 17:260-266
36. Masson LF, Sharp L, Cotton SC, Little J (2005) Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: A HuGE review. Am J Epidemiol 161:901-915. doi:10.1093/aje/kwi121
37. Quinones L, Lucas D, Godoy J, Caceres D, Berthou F et al (2001) CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174:35-44
38. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61
39. Kaklamani VG, Hou N, Bian Y, Reich J, Offit K et al (2003) TGFBR1*6A and cancer risk: A meta-analysis of seven casecontrol studies. J Clin Oncol 21:3236-3243. doi:10.1200/JCO. 2003.11.524
40. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16:2533-2547. doi: 10.1158/1055-9965.EPI-07-0708
41. Boland CR (2010) Chronic inflammation, colorectal cancer and gene polymorphisms.Dig Dis 28:590-595. doi:10.1159/000320053
42. Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA et al (2010) Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 59:1670-1679. doi:10.1136/gut.2009. 203000
43. Rheem DS, Baylink DJ, Olafsson S, Jackson CS, Walter MH (2010) Prevention of colorectal cancer with vitamin D. Scand J Gastroenterol 45:775-784. doi:10.3109/00365521003734125
44. Arain MA, Abdul Qadeer A (2010) Systematic review on "vitamin E and prevention of colorectal cancer". Pak J Pharm Sci 23:125-130